Episodes 106-120 of 762
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiersExploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiersImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
On the Frontlines of CIDPAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple SclerosisEnhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiersHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- advertisement
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiersInflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiersGut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Mapping Brain Atrophy in Schizophrenia
On the Frontlines of SchizophreniaMapping Brain Atrophy in Schizophrenia
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple SclerosisAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple SclerosisManaging MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- advertisement
Understanding Schizophrenia: Early Intervention and Prevention Strategies
On the Frontlines of SchizophreniaUnderstanding Schizophrenia: Early Intervention and Prevention Strategies
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
On the Frontlines of SchizophreniaOptimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiersReducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
